IL6 and non-small cell lung carcinoma: SB-203580 is a p38 MAPK-specific inhibitor that could suppress IL-6-stimulated non-small cell lung cancer cells proliferation by inhibiting IL-6-induced p38 MAPK phosphorylating activity (Chang et al., 2005).